Results 221 to 230 of about 40,111 (286)
EFSA Journal, Volume 23, Issue 5, May 2025.Abstract According to the ‘EFSA‐SANTE Action Plan on Cumulative Risk Assessment for pesticides residues’, EFSA initiated a retrospective cumulative risk assessment (CRA) of the effects of pesticide residues on the liver. For this CRA, EFSA identified the following liver‐specific effects in accordance with the International Harmonisation of Nomenclature
European Food Safety Authority (EFSA) +8 more
wiley +1 more source
EFSA Journal, Volume 23, Issue 5, May 2025.Abstract The food enzyme prolyl oligopeptidase (EC 3.24.21.26) is produced with the genetically modified Trichoderma reesei strain DP‐Nyq99 by Genencor international B.V. The genetic modifications do not give rise to safety concerns. The food enzyme was considered free from viable cells of the production organism and its DNA.
EFSA Panel on Food Enzymes (FEZ) +19 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Activated Partial Thromboplastin Time
Annals of Internal Medicine, 1986Excerpt To the editor: The statement by Drs. Suchman and Griner (1) that "normal APTT [activated partial thromboplastin time] and PT [prothrombin time] results essentially rule out a significant co...
Michael L. Bashevkin, Ismat U. Nawabi
openaire +6 more sources
The Effect of Increased Contact Activation Time on the Activated Partial Thromboplastin Time [PDF]
American Journal of Clinical Pathology, 1976 With the kaolin-cephalin activated partial thromboplastin time technic, the plasmas of persons who have Fletcher factor deficiency have shown considerable shortening of clotting times when contact activation has been lengthened from 3 (PTT-3) to 10 minutes (PTT-10).
Paul G. Hattersley, Dorothy Hayse
openaire +2 more sources
Erroneous Activated Partial Thromboplastin Time
Annals of Internal Medicine, 1978Excerpt To the editor: We wish to draw attention to the problem of erroneous results of activated partial thromboplastin times (aPTT) when plasma samples from patients on heparin are tested with th...
John Owen, Kelvin Carstairs, Eren Payne
openaire +3 more sources
Spurious Prolongation of the Activated Partial Thromboplastin Time
Thrombosis and Haemostasis, 1977SummaryThe clinical and laboratory data of 8 patients (4 males and 4 females) with circulating anticoagulant were presented. Based on prolonged APTT, failure to correct the APTT with 50 % normal plasma and abnormal tissue thromboplastin inhibition test, the inhibitor was identified as “middle stage” – or the “lupus anticoagulant”.
Okpara Ra, Carabello Ja, Day Hj
openaire +3 more sources
Effect of Warfarin on the Activated Partial Thromboplastin Time
Drug Intelligence & Clinical Pharmacy, 1986Outpatients followed in an anticoagulation clinic were studied retrospectively to determine the effect of warfarin on the activated partial thromboplastin time (APTT). Twenty-nine patients were studied in part 1 of the trial to determine whether their APTT values were elevated when their prothrombin time (PT) was within 1.5 to 2.5 times the control PT.
Valerie M. Hauser, Susan L. Rozek
openaire +2 more sources
The activated partial thromboplastin time (APTT) [PDF]
, 1992 The term partial thromboplastin is used to distinguish the reagent from that used in the prothrombin time, since the APTT reagent lacks the apoprotein component of the complete tissue thromboplastin. The APTT is the main test for screening for intrinsic clotting defects including haemophilia. It is also used for detection of lupus anticoagulant and for
L. Poller, J. M. Thomson
openaire +1 more source